Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Gas Gangrene

  • Author: Hoi Ho, MD; Chief Editor: Burke A Cunha, MD  more...
 
Updated: Nov 05, 2015
 

Background

Gas gangrene and clostridial myonecrosis are interchangeable terms used to describe an infection of muscle tissue by toxin-producing clostridia. In 1861, Louis Pasteur identified the first clostridial species, Clostridium butyricum. In 1892 and later, Welch, Nuttall, and other scientists isolated a gram-positive anaerobic bacillus from gangrenous wounds. This organism, originally known as Bacillus aerogenes capsulatus, was later renamed Bacillus perfringens, and then Clostridium welchii. The organism is now named Clostridium perfringens.

Gas gangrene gained recognition for its wartime incidence, during which only a paucity of civilian cases occurred. During World War I, gas gangrene complicated 6% of open fractures and 1% of all open wounds. These figures steadily decreased to 0.7% during World War II, 0.2% during the Korean War, and 0.002% during the Vietnam War. No cases of gas gangrene were reported during the battle in the Falkland Islands in 1982.[1]

Despite numerous casualties caused by enormous firepower and improvised explosive devices (IEDs), no cases of gas gangrene have been reported among US soldiers during the ongoing operation Iraqi Freedom. The lethality of war wounds has decreased from 24% during operation Desert Storm (1991) to an unprecedented 10% during operation Iraqi Freedom. The US military medicine has credited this to the mobility of the forward surgical teams (FSTs) in keeping up with the fast-moving military units.[2, 3, 4]

The incidence of gas gangrene was 0.96% in a study of 1970 survivors admitted to Sichuan Provincial People’s Hospital after the 2008 Wenchuan earthquake.[5] Another study of 226 patients during the same earthquake showed the importance of rapid and accurate screening, as well as isolation, in the successful treatment of gas gangrene and in helping to prevent nosocomial diffusion. Debridement, amputation, and supportive treatment yielded acceptable therapeutic results.[6]

Next

Pathophysiology

Gas gangrene is caused by an anaerobic, gram-positive, spore-forming bacillus of the genus Clostridium. C perfringens is the most common etiologic agent that causes gas gangrene. Other common clostridial species that cause gas gangrene include Clostridium bifermentans, Clostridium septicum, Clostridium sporogenes, Clostridium novyi, Clostridium fallax, Clostridium histolyticum, and Clostridium tertium.[7]

These organisms are true saprophytes and are ubiquitous in soil and dust. Clostridia have been isolated from the mucous membranes of humans, including the GI tract and the female genital tract. Clostridia may also colonize the skin, especially around the perineum. Clostridia are obligate anaerobes, but some species are relatively aerotolerant. Bacterial multiplication and the production of soluble proteins called exotoxins require a low oxygen tension.

Other bacteria are also capable of producing gas, and nonclostridial organisms have been isolated in 60-85% cases of gas gangrene. A recent clinical series on gas gangrene demonstrated a predominance (83.3%) of aerobic gram-negative bacilli in wound cultures compared with anaerobic gram-positive bacilli, with Clostridium species accounting for 4.5% of the isolates. The most frequently identified aerobic gram-negative bacteria were Escherichia coli,Proteus species, Pseudomonas aeruginosa, and Klebsiella pneumoniae.[7, 8, 9]

C perfringens produces at least 20 exotoxins. The most important exotoxins and their biologic effects are as follows:

  • Alpha toxin - Lethal,* lecithinase, necrotizing, hemolytic, cardiotoxic
  • Beta toxin - Lethal,* necrotizing
  • Epsilon toxin - Lethal,* permease
  • Iota toxin - Lethal,* necrotizing
  • Delta toxin - Lethal,* hemolysin
  • Phi toxin - Hemolysin, cytolysin
  • Kappa toxin - Lethal,* collagenase, gelatinase, necrotizing
  • Lambda toxin - Protease
  • Mu toxin - Hyaluronidase
  • Nu toxin - Lethal,* deoxyribonuclease, hemolytic, necrotizing
  • *Lethal as tested by injection in mice

Significant variance exists among clostridial species as to the mechanism of action of the alpha toxin. In C septicum, the alpha toxin forms pores and induces necrosis by causing the rapid loss of intracellular potassium and depletion of adenosine triphosphate (ATP). Strains that do not produce alpha-toxin are less virulent, underscoring its importance.[10] In mice models, alpha-toxin–induced lethality was inhibited by the preadministration of erythromycin. Erythromycin resulted in a reduction of the release of cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin 1, and interleukin 6. Additionally, TNF-alpha–deficient mice were resistant to C perfringens alpha-toxin, suggesting that TNF-alpha is an important contributor to the toxic effects of clostridial proteins.[11]

Genetic regulation of clostridial cytotoxic exotoxin production is under the control of several different regulatory systems, including the global VirR/VirS 2-component signal transduction system, and the RevR. The VirR, a membrane bound external sensor, and the VirS, a gene response regulator, together transmit and receive signals from the environment to the inside of the cell. The VirR/VirS system uses RNA intermediates to control 147 distinct genes and their associated operons.[12]

The phi-toxin is a hemolysin. Although it does not directly suppress myocardial function in vitro, it contributes to myocardial suppression in vivo, possibly by increasing the synthesis of secondary mediators that do suppress myocardial function in vitro. At higher concentrations, the phi-toxin can cause extensive cellular degeneration and direct vascular injury.

The kappa-toxin produced by C perfringens is a collagenase responsible for destruction of blood vessels and connective tissue. Other toxins include a deoxyribonuclease and hyaluronidase.

Contamination with clostridial spores in posttraumatic or postoperative lesions establishes the initial stage of infection. Local wound conditions are more important than the degree of clostridial contamination in the development of gas gangrene. Disrupted or necrotic tissue provides the necessary enzymes and a low oxidation/reduction potential, allowing for spore germination. Foreign bodies, premature wound closure, and devitalized muscle reduce the spore inoculum necessary to cause infection in laboratory animals.

The typical incubation period for gas gangrene is frequently short (ie, < 24 h), but incubation periods of 1 hour to 6 weeks have been reported. Self-perpetuating destruction of tissue occurs via a rapidly multiplying microbial population and the production of locally and systemically acting exotoxins. Local effects include necrosis of muscle and subcutaneous fat and thrombosis of blood vessels. Marked edema may further compromise blood supply to the region. Fermentation of glucose is probably the main mechanism of gas production in gas gangrene. In C septicum spontaneous gas gangrene, nitrogen is the predominant gas component (74.5%), followed by oxygen (16.1%), hydrogen (5.9%), and carbon dioxide (3.4%). Production of hydrogen sulfide and carbon dioxide gas begins late and dissects along muscle bellies and fascial planes. These local effects create an environment that facilitates rapid spread of the infection.[13]

Systemically, exotoxins may cause severe hemolysis. Hemoglobin levels may drop to very low levels and, when occurring with hypotension, may cause acute tubular necrosis and renal failure. A rapidly progressive infection can quickly result in shock. The mechanism of shock is poorly understood. Unconcentrated filtrate from C perfringens, purified alpha-toxin, and purified phi-toxins cause hypotension, bradycardia, and decreased cardiac output when injected into laboratory animals. Because alpha-toxins and phi-toxins are lipophilic and may remain locally bound to tissue plasma membranes, the toxins may stimulate synthesis of secondary mediators that cause cardiovascular abnormalities.

Previous
Next

Epidemiology

Frequency

United States

Clostridia species are ubiquitous and widely distributed in the soil, especially in cultivated land. The density of clostridia in the soil is a contributing factor in the development of trauma-related gas gangrene. Civilian cases of gas gangrene are more common, with approximately 3000 cases per year. Gas gangrene can be classified as posttraumatic, postoperative, or spontaneous. Posttraumatic gas gangrene accounts for 60% of the overall incidence; most cases involve automobile collisions.[14]

From 1998-2002, C septicum was implicated in causing serious infections in recipients of contaminated musculoskeletal-tissue allografts. In addition, 5 pediatric patients who had hemolytic uremic syndrome (HUS) secondary to infection by Escherichia coli O157 were later infected by C septicum with fatal complications.[15] Recently, Clostridium sordellii, an uncommon human pathogen, caused fatal toxic shock syndrome, bacteremia, and extensive endometritis in 4 young women who underwent medical abortion with oral mifepristone and vaginal misoprostol.[16]

International

From April 2000 to June 2000, several users of injection drugs in Scotland, Ireland, and England developed serious clostridial infections (C novyi and C perfringens) complicated by a high mortality rate (97%). Most of these patients reported injecting heroin intramuscularly within the previous two weeks.[17]

With more than 200,000 liposuctions performed in Germany in 2003, several serious complications had been reported. Necrotizing fasciitis and gas gangrene were the most frequent, major and lethal complications observed in a review of 72 cases of complications caused by liposuction performed in Germany between 1998 and 2002.[18]

A tsunami ravaged Indonesia in December 2004 and killed more than 200,000 Indonesians. Soaking in contaminated water, several injured persons later died of tetanus or gas gangrene.

In May 2008, the Sichuan earthquake in China caused more than 70,000 deaths and approximately 400,000 injuries; several injured persons developed gas gangrene and later underwent amputations. Among 2131 survivors admitted to a public hospital in the Sichuan area, at least 19 patients (0.9%) developed gas gangrene.[5]

Mortality/Morbidity

Gas gangrene is undoubtedly an infection that carries a very high mortality rate. The reported mortality rates vary widely, with a rate of 25% in most recent studies. The mortality rate approaches 100% in individuals with spontaneous gas gangrene and in those in whom treatment is delayed.[19, 20]

Sex

Gas gangrene has no reported sexual predilection, and the sex of the individual does not affect the outcome.

Age

Although age is not a prognostic factor in gas gangrene, advanced age and comorbid conditions are associated with a higher likelihood of mortality.

Previous
 
 
Contributor Information and Disclosures
Author

Hoi Ho, MD Associate Dean for Faculty Affairs and Development, Professor, Department of Internal Medicine, Director, Center for Advanced Teaching and Assessment in Clinical Simulation (ATACS), Paul L Foster School of Medicine, Texas Tech University Health Sciences Center; Consulting Physician, University Medical Center

Hoi Ho, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American College of Forensic Examiners Institute, American College of Physicians, American Society for Microbiology, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Coauthor(s)

Enes Kanlic, MD Professor, Department of Orthopedic Surgery, Texas Tech University Health Science Center

Disclosure: Nothing to disclose.

Lorenzo B Aragon, MD Associate Professor, Department of Family Medicine, Paul L Foster Texas Tech University Health Sciences Center; Medical Director, Ambrosio Guillen Texas State Veterans Home

Lorenzo B Aragon, MD is a member of the following medical societies: American Academy of Family Physicians, AMDA - The Society for Post-Acute and Long-Term Care Medicine, Society of Teachers of Family Medicine, Texas Medical Association

Disclosure: Nothing to disclose.

Juan B Figueroa-Casas, MD Associate Professor, Division of Pulmonary and Critical Care Medicine, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Disclosure: Nothing to disclose.

David G Maxfield Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

David G Maxfield is a member of the following medical societies: American College of Physicians, Texas Medical Association, Congress of Neurological Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Charles V Sanders, MD Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: American College of Physicians, Alliance for the Prudent Use of Antibiotics, The Foundation for AIDS Research, Southern Society for Clinical Investigation, Southwestern Association of Clinical Microbiology, Association of Professors of Medicine, Association for Professionals in Infection Control and Epidemiology, American Clinical and Climatological Association, Infectious Disease Society for Obstetrics and Gynecology, Orleans Parish Medical Society, Southeastern Clinical Club, American Association for the Advancement of Science, Alpha Omega Alpha, American Association of University Professors, American Association for Physician Leadership, American Federation for Medical Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association of American Medical Colleges, Association of American Physicians, Infectious Diseases Society of America, Louisiana State Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southern Medical Association

Disclosure: Received royalty from Baxter International for other.

Chief Editor

Burke A Cunha, MD Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

Pranatharthi Haran Chandrasekar, MBBS, MD Professor, Chief of Infectious Disease, Program Director of Infectious Disease Fellowship, Department of Internal Medicine, Wayne State University School of Medicine

Pranatharthi Haran Chandrasekar, MBBS, MD is a member of the following medical societies: American College of Physicians, American Society for Microbiology, International Immunocompromised Host Society, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthors Jeffrey P Nelson, MD; Miguel Angel Pena-Ruiz, MD; and Karl C Bentley, MS, to the development and writing of this article.

References
  1. Chapnick EK, Abter EI. Necrotizing soft-tissue infections. Infect Dis Clin North Am. 1996 Dec. 10(4):835-55. [Medline].

  2. Gawande A. Casualties of war--military care for the wounded from Iraq and Afghanistan. N Engl J Med. 2004 Dec 9. 351(24):2471-5. [Medline].

  3. Murray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR. Prevention and management of infections associated with combat-related extremity injuries. J Trauma. 2008 Mar. 64(3 Suppl):S239-51. [Medline].

  4. U.S. casualty status. Department of Defense, 2004. Available at http://www.defenselink.mil/news/casualty.pdf.

  5. Wang Y, Hao P, Lu B, Yu H, Huang W, Hou H, et al. Causes of infection after earthquake, China, 2008. Emerg Infect Dis. 2010 Jun. 16(6):974-5. [Medline]. [Full Text].

  6. Wang Y, Lu B, Hao P, Yan MN, Dai KR. Comprehensive treatment for gas gangrene of the limbs in earthquakes. Chin Med J (Engl). 2013 Oct. 126(20):3833-9. [Medline].

  7. De A, Varaiya A, Mathur M, Bhesania A. Bacteriological studies of gas gangrene and related infections. Indian J Med Microbiol. 2003 Jul-Sep. 21(3):202-4. [Medline]. [Full Text].

  8. Hart GB, Lamb RC, Strauss MB. Gas gangrene. J Trauma. 1983 Nov. 23(11):991-1000. [Medline].

  9. Nichols RL, Smith JW. Anaerobes from a surgical perspective. Clin Infect Dis. 1994 May. 18 Suppl 4:S280-6. [Medline].

  10. Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, et al. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. 2010 Jan. 55(1):61-72. [Medline].

  11. Oda M, Kihara A, Yoshioka H, Saito Y, Watanabe N, Uoo K. Effect of erythromycin on biological activities induced by clostridium perfringens alpha-toxin. J Pharmacol Exp Ther. 2008 Dec. 327(3):934-40. [Medline].

  12. Ohtani K, Hirakawa H, Tashiro K, Yoshizawa S, Kuhara S, Shimizu T. Identification of a two-component VirR/VirS regulon in Clostridium perfringens. Anaerobe. 2010 Jun. 16(3):258-64. [Medline].

  13. Stevens DL, Musher DM, Watson DA, et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis. 1990 Mar-Apr. 12(2):286-96. [Medline].

  14. Brown PW, Kinman PB. Gas gangrene in a metropolitan community. J Bone Joint Surg [Am]. 1974 Oct. 56(7):1445-51. [Medline].

  15. Barnham M, Weightman N. Clostridium septicum infection and hemolytic uremic syndrome. Emerg Infect Dis. 1998 Apr-Jun. 4(2):321-4. [Medline]. [Full Text].

  16. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med. 2005 Dec 1. 353(22):2352-60. [Medline].

  17. McGuigan CC, Penrice GM, Gruer L, Ahmed S, Goldberg D, Black M. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol. 2002 Nov. 51(11):971-7. [Medline].

  18. Lehnhardt M, Homann HH, Daigeler A, Hauser J, Palka P, Steinau HU. Major and lethal complications of liposuction: a review of 72 cases in Germany between 1998 and 2002. Plast Reconstr Surg. 2008 Jun. 121(6):396e-403e. [Medline].

  19. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005 Nov 15. 41(10):1373-406. [Medline].

  20. Takazawa K, Otsuka H, Nakagawa Y, Inokuchi S. Clinical Features of Non-clostridial Gas Gangrene and Risk Factors for In-hospital Mortality. Tokai J Exp Clin Med. 2015 Sep 20. 40 (3):124-9. [Medline].

  21. Larson CM, Bubrick MP, Jacobs DM, West MA. Malignancy, mortality, and medicosurgical management of Clostridium septicum infection. Surgery. 1995 Oct. 118(4):592-7; discussion 597-8. [Medline].

  22. Chen E, Deng L, Liu Z, Zhu X, Chen X, Tang H. Management of gas gangrene in Wenchuan earthquake victims. J Huazhong Univ Sci Technolog Med Sci. 2011 Feb. 31(1):83-7. [Medline].

  23. Zacharias N, Velmahos GC, Salama A, Alam HB, de Moya M, King DR. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010 May. 145(5):452-5. [Medline].

  24. Hopkins KL, Li KC, Bergman G. Gadolinium-DTPA-enhanced magnetic resonance imaging of musculoskeletal infectious processes. Skeletal Radiol. 1995 Jul. 24(5):325-30. [Medline].

  25. Butcher CH, Dooley RW, Levitov AB. Detection of subcutaneous and intramuscular air with sonography: a sensitive and specific modality. J Ultrasound Med. 2011 Jun. 30(6):791-5. [Medline].

  26. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 1997 Nov. 90(11):1065-8. [Medline].

  27. Ustin JS, Malangoni MA. Necrotizing soft tissue infections. Crit Care Med. 2011 Apr 28. [Medline].

  28. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis. 1987 Feb. 155(2):220-8. [Medline].

  29. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother. 2001 Apr. 45(4):1238-43. [Medline].

  30. Khanna N. Clindamycin-resistant Clostridium perfringens cellulitis. J Tissue Viability. 2008 Aug. 17(3):95-7. [Medline].

  31. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8. 344(10):699-709. [Medline].

  32. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005 Sep 29. 353(13):1332-41. [Medline].

  33. Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin Infect Dis. 1993 Aug. 17(2):231-7. [Medline].

  34. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994 May. 167(5):485-9. [Medline].

  35. George ME, Rueth NM, Skarda DE, Chipman JG, Quickel RR, Beilman GJ. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009 Feb. 10(1):21-8. [Medline].

  36. Shaw JJ, Psoinos C, Emhoff TA, Shah SA, Santry HP. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt). 2014 Jun. 15 (3):328-35. [Medline].

  37. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996 Jun 20. 334(25):1642-8. [Medline].

  38. Monturiol-Gross L, Flores-Díaz M, Campos-Rodríguez D, Mora R, Rodríguez-Vega M, Marks DL, et al. Internalization of Clostridium perfringens a-toxin leads to ERK activation and is involved on its cytotoxic effect. Cell Microbiol. 2013 Nov 18. [Medline].

  39. Determann C, Walker CA. Clostridium perfringens gas gangrene at a wrist intravenous line insertion. BMJ Case Rep. 2013 Oct 9. 2013:[Medline].

 
Previous
Next
 
A patient developed gas gangrene after injecting cocaine. Clostridium septicum was isolated in both blood and wound cultures.
Gas feathering in the arm soft tissue of a patient with gas gangrene.
Extension of gas gangrene to the chest wall despite initial debridement.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.